image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

T Clarke

March 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CTO
  • Price:
  • 146p
Trading in H2 remained strong and in line. The group anticipates turnover for FY22 of c£425m (slightly ahead of recently revised forecasts) and pretax profit of £10.3m (FY21: £7.8m, +32%). Putting this growth into perspective, FY22 revenue will have increased by almost £100m (+30%) and eps by c30% YoY to 19.3p, underlining the continued momentum. Encouragingly, the order book stepped up to £555m (2021: £534m), providing excellent visibility going into FY23 with good momentum in its core markets and significant opportunities in data centres, healthcare, and energy efficient smart building solutions. Liquidity remains strong; net cash was £7.5m and its average month end net cash during the year was £2.6m. The group has a further £10m of re ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author